Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > RuBCG HUGE POTENTIAL

<< Previous

Bullboard Posts

Next >>

Post by Tarbabyon Jul 11, 2024 1:44pm

261 Views

Post# 36128700

RuBCG HUGE POTENTIAL

Their discovery that Rudivar combined with BCG increased the effectivness of BCG is potentially a huge game changer for bladder cancer treatment.
That alone might be worth billions..
They have so many cookies in their cookie jar..

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?